Literature DB >> 20824365

Prophylactic pancreatectomy for intraductal papillary mucinous neoplasm does not negatively impact quality of life: a preliminary study.

Minna K Lee1, Joseph DiNorcia, Lisa J Pursell, Marc M Holden, Wei-Yann Tsai, Peter D Stevens, Nicole Goetz, Victor R Grann, John A Chabot, John D Allendorf.   

Abstract

BACKGROUND: Uncertainties remain over whether prophylactic surgery or surveillance is the better management option for intraductal papillary mucinous neoplasm of the pancreas. The aim of this preliminary study was to determine if differences in anxiety and quality of life exist between patients who have surgery or undergo surveillance.
METHODS: Recruited patients were given the Hospital Anxiety and Depression Scale, a general survey that evaluates anxiety, and the Functional Assessment of Cancer Therapy-Pancreas, a disease-specific survey that assesses quality of life. Questionnaires were scored by standardized algorithms and compared using Student's t test or Wilcoxon rank-sum test.
RESULTS: Sixteen patients had surgery and 16 patients were undergoing surveillance. Mean age was 66.8 ± 19.9 years. Responses from both groups were remarkably similar. Surgery patients scored higher on the anxiety questionnaire than surveillance patients, although not statistically significant (p = 0.09). Surgery patients scored lower on the functional well-being domain of the quality-of-life instrument (p = 0.03), though there were no differences in overall quality of life.
CONCLUSION: Prophylactic surgery does not reduce quality of life, and a protocol of surveillance does not appear to generate undue anxiety in this select patient group. Further investigation with more patients is required to validate these findings.

Entities:  

Mesh:

Year:  2010        PMID: 20824365     DOI: 10.1007/s11605-010-1346-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews.

Authors:  M B Hatcher; L Fallowfield; R A'Hern
Journal:  BMJ       Date:  2001-01-13

Review 3.  Pathology of cancer of the pancreas.

Authors:  R E Wilentz; R H Hruban
Journal:  Surg Oncol Clin N Am       Date:  1998-01       Impact factor: 3.495

4.  Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

Authors:  Michelle L DeOliveira; Jordan M Winter; Markus Schafer; Steven C Cunningham; John L Cameron; Charles J Yeo; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 5.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

6.  Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

Authors:  Seiko Hirono; Masaji Tani; Manabu Kawai; Shinomi Ina; Ryohei Nishioka; Motoki Miyazawa; Yoichi Fujita; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Arch Surg       Date:  2009-04

Review 7.  Genetic alterations in the adenoma--carcinoma sequence.

Authors:  K R Cho; B Vogelstein
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

8.  Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.

Authors:  C J Lee; J Scheiman; M A Anderson; O J Hines; H A Reber; J Farrell; M L Kochman; P J Foley; J Drebin; Y S Oh; G Ginsberg; N Ahmad; N B Merchant; J Isbell; A A Parikh; J B Stokes; T Bauer; R B Adams; D M Simeone
Journal:  J Gastrointest Surg       Date:  2007-11-27       Impact factor: 3.452

9.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.